TSANZ SIG Orals: Asthma & Allergy 1
Tracks
TSANZ Orals
| Saturday, March 22, 2025 |
| 3:30 PM - 5:00 PM |
Speaker
Dr Mike Forrester
Paediatrician And Senior Research Fellow
Deakin University
The National Sustainable Asthma Care Roadmap – Roundtable Report
3:30 PM - 3:45 PM
Dr Michael Fricker
Research Fellow
University Of Newcastle
Differential impact of IL5 pathway biologics on IL5R-expressing mast cell progenitors in severe asthma
3:45 PM - 4:00 PM
Prof David Langton
Director, Thoracic Medicine
Peninsula Health
Real-world study of anti-IL5 biologicals five years post initiation
4:00 PM - 4:15 PM
Prof David Price
Director Of Observational and Pragmatic Research Institute
Observational and Pragmatic Research Institute
Systematic corticosteroid increases healthcare costs in Australian patients with asthma
4:15 PM - 4:30 PM
Prof David Price
Director Of Observational and Pragmatic Research Institute
Observational and Pragmatic Research Institute
Characteristics of asthma patients escalating from msICS/LABA to hsICS/LABA or msBDP/FF/G
4:30 PM - 4:45 PM
Prof Peter Wark
Professor
Alfred Health
Mepolizumab is not inferior to omalizumab, improving asthma control in severe allergic and eosinophilic asthma, a randomised, blinded, non-inferiority trial.
4:45 PM - 5:00 PM
